Acumen Pharmaceuticals Inc ABOS Balance Sheet

Quarter End	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024
	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)
Total Assets	196.59M	187.86M	177.41M	286.37M	310.13M	300.97M	288.91M	266.98M
Total Current Assets	180.33M	144.03M	149.54M	218.6M	246.62M	255.83M	266.92M	207.63M
Cash and Equivalents	130.1M	78M	77.25M	94.92M	66.89M	46.93M	67.96M	33.18M
Total Non-Current Assets	16.42M	43.83M	27.87M	67.77M	63.51M	45.14M	22M	59.34M
Total Liabilities	7.81M	8.78M	8.53M	6.1M	43.15M	38.93M	44.97M	49.77M
Total Current Liabilities	7.81M	8.78M	8.53M	6.1M	12.97M	8.47M	15.37M	19.91M
Total Non-Current Liabilities	0	0	0	0	60.08M	60.67M	58.98M	59.53M
Common Equity	4k	4k	4k	6k	6k	6k	6k	6k
Retained Earnings	-170.43M	-181.73M	-193.34M	-206.3M	-222.8M	-237.67M	-258.21M	-287.97M

Year End December 30 2023	2019	2020	2021	2022	2023
	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)
Total Assets	7.32M	44.43M	230.33M	196.59M	310.13M
Total Current Assets	7.18M	44.43M	198.66M	180.33M	246.62M
Cash and Equivalents	6.55M	43.78M	122.16M	130.1M	66.89M
Total Non-Current Assets	-11.42M	-18.59M	225.18M	188.78M	266.97M
Total Liabilities	1.34M	6.37M	5.15M	7.81M	43.15M
Total Current Liabilities	1.34M	6.37M	5.15M	7.81M	12.97M
Total Non-Current Liabilities	0	0	0	0	60.08M
Total Equity	-11.42M	-18.59M	225.18M	188.78M	266.97M
Common Equity	0	0	4k	4k	6k
Retained Earnings	-19.64M	-26.97M	-127.57M	-170.43M	-222.8M